Grade 3 or higher adverse events were noted in around 22% of patients, including colitis, diarrhea, fatigue, increased aspartate transaminase (AST) or alanine transaminase (ALT) levels, neutropenia, hyponatremia, and lymphopenia. The gene discussed is GPT; the disease is colitis.